Eric Topol
@EricTopol
ยท
2h
Just published
@NEJM
:
@Novavax
‘s protein-based vaccine trial in over 15,000 participants . The efficacy of 96% for non-Alpha variant, 86% vs Alpha, very good safety data, all akin to the excellent results of the mRNA vaccines https://nejm.org/?query=featured_home&doi=10.1056%2FNEJMoa2107659
I feel dirty posting anything published in the Atlantic, but it’s a good read regarding the Noravax vaccine.
https://www.theatlantic.com/health/archive/2021/06/novavax-now-best-covid-19-vaccine/619276/